Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2009 Mar;96(3):85-90.
doi: 10.1016/j.ymgme.2008.09.008. Epub 2009 Jan 20.

A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency

Georgianne L Arnold  1 , Johan Van Hove, Debra Freedenberg, Arnold Strauss, Nicola Longo, Barbara Burton, Cheryl Garganta, Can Ficicioglu, Stephen Cederbaum, Cary Harding, Richard G Boles, Dietrich Matern, Pranesh Chakraborty, Annette Feigenbaum
Affiliations
Practice Guideline

A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency

Georgianne L Arnold et al. Mol Genet Metab. 2009 Mar.

Abstract

Introduction: Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is a disorder of oxidation of long chain fat, and can present as cardiomyopathy or fasting intolerance in the first months to years of life, or as myopathy in later childhood to adulthood. Expanded newborn screening has identified a relatively high incidence of this disorder (1:31,500), but there is a dearth of evidence-based outcomes data to guide the development of clinical practice protocols. This consensus protocol is intended to assist clinicians in the diagnosis and management of screen-positive newborns for VLCAD deficiency until evidence-based guidelines are available.

Method: The Oxford Centre for Evidence-based Medicine system was used to grade the literature review and create recommendations graded from A (evidence level of randomized clinical trials) to D (expert opinion). Delphi was used as the consensus tool. A panel of 14 experts (including clinicians, diagnostic laboratory directors and researchers) completed three rounds of survey questions and had a face-to-face meeting.

Result: Panelists reviewed the initial evaluation of the screen-positive infant, diagnostic testing and management of diagnosed patients. Grade C and D consensus recommendations were made in each of these three areas. The panel did not reach consensus on all issues, particularly in the dietary management of asymptomatic infants diagnosed by newborn screening.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gregerson N, Andresen BS, Corydon MJ, Corydon TJ, Olsen R, Bolund L, Bross P. Mutation anaysis in mitochondrial fatty acid oxidation defects, exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype–phenotype relationship. Hum Mutat. 2001;18:169–189. - PubMed
    1. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors if metabolism. J Inherit Metab Dis. 1990;13:321–324. - PubMed
    1. Boneh A, Andresen BS, Gregersen N, Ibrahim M, Tzanakos N, Peters H, Yaplito-Lee Y, Pitt JJ. VLCAD deficiency: Pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab. 2006;88:166–170. - PubMed
    1. Centre for Evidence-Based Medicine. [May 2, 2008]. Available from: < http://www.cebm.net/levels_of_evidence.asp>.
    1. Linstone HA, Turof M. The Delphi method: techniques and applications. Addison-Wesley Pub Co.; Reading, Mass: 1975. [May 1, 2008]. Available from: < http://is.njit.edu/pubs/delphibook/delphibook.pdf>.

Publication types

Substances